THE NEUROSURGICAL FOUNDATION

Registered charity 1162599 · accounts filings on the Charity Commission register · also known as TNF

To promote and encourage the advancement of medical learning in the field of neurosurgery.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Get email alerts

Latest income
£95k
Latest spending
£90k
Registered
2015
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that unrestricted funds increased by £5,242 to £389,996, resulting in a net income surplus for the year. The charity maintains a reserves policy target of £60,000, which is comfortably exceeded by its current unrestricted reserves. No material uncertainties or going concern issues were identified by the independent examiner.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: five times its annual standing costs. This amount is £60K (held: £390k)
The Foundation seeks to maintain its uncommitted reserves at five times its annual standing costs. This amount is £60K — page 5
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: City Of Westminster · Newcastle Upon Tyne City

Income and spending

Financial year endIncomeSpending
31/10/2025£95k£90k
31/10/2024£53k£45k
31/10/2023£61k£25k
31/10/2022£61k£17k
31/10/2021£60k£15k

Common questions

Is THE NEUROSURGICAL FOUNDATION financially healthy?

Per its FY2025 accounts: The accounts state that unrestricted funds increased by £5,242 to £389,996, resulting in a net income surplus for the year. The charity maintains a reserves policy target of £60,000, which is comfortably exceeded by its current unrestricted reserves. No material uncertainties or going concern issues were identified by the independent examiner. Its FY2025 accounts were independently examined.